Cyclophosphamide 500mg/2.5mL
| Product Overview | |
| Generic Name | Cyclophosphamide 500mg/2.5mL |
| Brand Name(s) | Cytoxan |
| Product Type | Biosimilar |
| Form | vial, IV solution |
| Strength | 500 mg/2.5 mL |
| Therapeutic Class | Alkylating agent; nitrogen mustard derivative |
| ATC Code | L01AA01 |
| Manufacturing & Regulatory | |
| Manufacturer | Bristol-Myers Squibb |
| Country | Canada, USA, Mexico, India |
| GMP Compliance | WHO-GMP certified |
| DMF/CEP | Type II DMFs |
| COFEPRIS | 010.000.1753.01 |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 units |
| Shelf Life | 36 months |
| Storage | 2–8 °C |
| Incoterms | Ex-Works, 30049041 |
| Lead Time | 7 to 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
| CTD Summary | Not publicly available as parallel traded molecule |
Description
Solución inyectable. Cada frasco ámpula o vial con liofilizado contiene ciclofosfamida monohidratada equivalente a 500 mg de ciclofosfamida. Envase con 1 frasco ámpula o vial.
